venBio is a venture capital firm focused on life sciences investments, partnering with industry leaders to develop novel therapeutics and technologies for unmet medical needs. Founded in 2011, its funds total about $1.1 billion in committed capital, and it supports portfolio companies through IP, chemistry/manufacturing (CMC), and clinical trial planning to position them for success and potential acquisition. The firm emphasizes patient impact and close collaboration with leadership, with offices in San Francisco and Seattle.
We haven’t found venBio Partners in the AI answers we’ve checked.
Brand page for venbio-com